• Medical_Professionals
• Medical_students
• Nurses

Like many areas of medicine, gastroenterological management continues to evolve. This symposium addresses some important areas of disease management which is being informed by new evidence (such as alcoholic hepatitis and acute severe colitis). The gut microbiome is an emerging and rapidly expanding area of research endeavour that seems likely to impact not only on gut and liver health and disease but on many other parts of the human body so it is appropriate to review this. A major public health problem, hepatitis C, is reviewed with respect to challenges of identifying and treating asymptomatic cases. While there are now highly effective treatments, there is a debate to be had balancing affordability with the risks and expense of managing advanced liver disease in the future. This leads onto the issues of the need for palliative treatment in advanced liver disease: recognition of the palliative needs of end stage liver disease patients and how this sits with being on a liver transplant list.

Endoscopic treatments continue to evolve and the technical ability to diagnose early neoplasia have improved, so it is appropriate to review what can be achieved and to understand where endoscopic therapy may be heading in the future.

Finally, some areas of common clinical practice, where symptoms are at variance with normal endoscopic findings, are identified and explored in a practical and interactive session.

Professor John de Caestecker

Chair, Organising Committee

GBP

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Submission Info

Anne Fairbairn , Education Co-ordinator , RCPE

Phone: 011-44-13-1247-3649

Fax: 011-44-13-1220-4393

Email: a.fairbairn@rcpe.ac.uk

Anne Fairbairn , Education Co-ordinator , RCPE

Phone: 011-44-13-1247-3649

Fax: 011-44-13-1220-4393

Email: a.fairbairn@rcpe.ac.uk